The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of RAS and BRAF heterogeneity on the efficacy of EGFR blockade in patients with metastatic colorectal cancer.
 
Takeshi Yamada
No Relationships to Disclose
 
Nobuhisa Matsuhashi
No Relationships to Disclose
 
Takao Takahashi
No Relationships to Disclose
 
Keiji Hirata
No Relationships to Disclose
 
Takeshi Nagasaka
No Relationships to Disclose
 
Yuki Nakamura
No Relationships to Disclose
 
Kazuhiro Sakamoto
No Relationships to Disclose
 
Keiji Koda
No Relationships to Disclose
 
Kazuhiro Hiramatsu
No Relationships to Disclose
 
Hiroshi Matsuoka
No Relationships to Disclose
 
Hidekazu Kuramochi
No Relationships to Disclose
 
Hideyuki Ishida
No Relationships to Disclose
 
Kozo Kataoka
No Relationships to Disclose
 
Hajime Yokomizo
No Relationships to Disclose
 
Yoshinori Kagawa
Consulting or Advisory Role - Lilly; Merck; Taiho Pharmaceutical
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Ono Pharmaceutical
 
Mitsukuni Suenaga
No Relationships to Disclose
 
Ryo Ohta
No Relationships to Disclose
 
Akihisa Matsuda
No Relationships to Disclose
 
Hiroshi Yoshida
No Relationships to Disclose